VSTM2A antibody (Middle Region)

Catalog No. ABIN633890

Product Details anti-VSTM2A Antibody

Target: VSTM2A (V-Set and Transmembrane Domain Containing 2A (VSTM2A))

Binding Specificity: Middle Region

Reactivity: Mouse, Human, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This VSTM2A antibody is un-conjugated

Application: Western Blotting (WB)

Specificity: VSTM2 A antibody was raised against the middle region of VSTM2

Purification: Affinity purified

Immunogen: VSTM2 A antibody was raised using the middle region of VSTM2 corresponding to a region with amino acids DISHKLQISKVRKKDEGLYECRVTDANYGELQEHKAQAYLKVNANSHARR

Application Details

Application Notes: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

VSTM2A Blocking Peptide, catalog no. 33R-2006, is also available for use as a blocking control in assays to test for specificity of this VSTM2A antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of VSTM0 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Target Details for VSTM2A

Target: VSTM2A (V-Set and Transmembrane Domain Containing 2A (VSTM2A))

Alternative Name: VSTM2A (VSTM2A Products)

Background: This pseudogene is a member of the cytochrome P450 geneuperfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. It is possible that, in rare cases, a combination of two SNPs in this gene may result in an open reading frame encoding a functional enzyme which metabolizes codeine to morphine.

Molecular Weight: 26 kDa (MW of target protein)